|
|||||
|
|
| rIL－2/LAK细胞治疗晚期恶性肿瘤 | |
| 引用本文： | 张月桂 尤庆山. rIL－2/LAK细胞治疗晚期恶性肿瘤[J]. 肿瘤防治研究, 1995, 22(1): 12-13 |
| 作者姓名： | 张月桂 尤庆山 |
| 作者单位： | 1. 黑龙江省肿瘤研究所; 2. 黑龙江省肿瘤医院 |
| 摘 要： | 胎儿来源的LAK细胞/rIL-2对5例失去手术、化疗、放疗机会的晚期恶性肿瘤病人进行了过继免疫治疗。结果都取得了-定的疗效,黑色素瘤病人肺转移结节基本消失,局部瘤细胞全部坏死,组织细胞正常;淋巴瘤病人转移灶消退59%;小肠平滑肌肉瘤病人在没进行此疗法之前2年半复发、手术三次。第三次手术后用此疗法治疗-个疗程,三年后第-次复发。为晚期恶性肿瘤病人延长了生命,提高了生存质量争得了再次治疗的机会。 |
| 关 键 词： | 基因重组 白细胞介素2 癌 免疫疗法 LAK细胞 |
Treatment of Patients with Advanced Malibnant Tumor by Transfor LAK Cells Combined with rIL-2 |
|
| Zhang Yuegui. Treatment of Patients with Advanced Malibnant Tumor by Transfor LAK Cells Combined with rIL-2[J]. Cancer Research on Prevention and Treatment, 1995, 22(1): 12-13 | |
| Authors: | Zhang Yuegui |
| Affiliation: | Cancer Institute: Helongjiang Harbin 150040 |
| Abstract: | Five advanced malignant tumor were treated with LAK cells isolated from human fetal spleen combined with rIL-2. One patient with malignant melanoma had metastasis tumor dispeared in one lung and significantly reduced in the other. The matastasis lesion of one patient with lymphoma de-creased 59% after treatment, a patient with intestinal smooth muscle sarcoma had prolonged relapse by administrated LAK/rIL-2" NO serious effects were observed. The results indicated that LAK/ rIL-2 in the treatment of patient with advanced malignant tumor is effect and safe. |
| Keywords: | Lymphoma-activated kill cell (LAK cell) Recombined interleukin-2 (rIL-2) Fetal Immunotberapy |
| 本文献已被 维普 等数据库收录！ | |
| 点击此处可从《肿瘤防治研究》浏览原始摘要信息 | |
| 点击此处可从《肿瘤防治研究》下载全文 | |